All About Multiple Sclerosis

More MS news articles for September 2003

Study of Copaxone for multiple sclerosis

Zh Nevrol Psikhiatr Im S S Korsakova. 2003;Spec No 2:91-7

146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre.

The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment.

EDSS score did not increase both in group with and without relapses.

The condition of 2/3 patients was stable.

To achieve the best effect of treatment the program of patient support was successfully used in the Moscow MS Centre.